May 30, 2024 11:18 AM EDT
R&D

The bio­phar­ma news we’re pay­ing at­ten­tion to at AS­CO

Lei Lei Wu

News Reporter

More than 40,000 peo­ple are ex­pect­ed to con­gre­gate in Chica­go this week for the Amer­i­can So­ci­ety of Clin­i­cal On­col­o­gy’s an­nu­al meet­ing, and an es­ti­mat­ed 5 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Bris­tol My­ers re­veals more job cuts in New Jer­sey

Mer­ck halts Phase 3 tri­al with PAH drug Win­re­vair fol­low­ing pos­i­tive in­ter­im da­ta 

In­cyte touts Mon­ju­vi da­ta from Phase 3 fol­lic­u­lar lym­phoma tri­al as it heads to FDA

As­traZeneca’s Truqap edges clos­er to prostate can­cer la­bel ex­pan­sion with Phase 3 win

A service from the Financial Times